Physician profile
Samee Alheraki
NPI 1598442956
$468.11
in general payments reported to CMS, 2019-2025
10 companies · $40.25 in 2025
The $40.25 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $28.07 · 2024: $400 · 2025: $40.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $468.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $234.53 | 2024 | Rezdiffra |
| Boston Scientific Corporation | $77.06 | 2024 | Watchman Flx |
| Janssen Pharmaceuticals, INC | $28.07 | 2023 | Xarelto |
| Daiichi Sankyo INC. | $24.23 | 2024 | Injectafer |
| Exact Sciences Corporation | $23.29 | 2025 | Cologuard Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $19.47 | 2024 | Opdivo |
| Lilly USA, LLC | $16.96 | 2025 | Zepbound |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.61 | 2024 | Lifevest |
| Irhythm Technologies, INC. | $14.13 | 2024 | Zio Monitor, Zio Xt Patch |
| Abiomed | $13.76 | 2024 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samee Alheraki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.